Solventum (SOLV) has been in focus among investors as the stock showed some movement over the past week, catching attention because of changes in its recent performance and valuation. See our latest ...

Solventum, Minnesota’s newest Fortune 500 company, is finding its footing after starting its first full year of operations on shakier ground. The 3M spinoff commenced 2025 with a deflated stock, which ...

*Data in the schedule above is intentionally rounded to the nearest million and, therefore, may not sum. 2 Constant currency represents the change in net sales absent the impact on sales from foreign ...

Solventum, the recently spun off healthcare arm of 3M, faces challenges in value creation due to stagnant growth, heavy debt burden, and entanglement with its former parent. The company's revenue ...

Summary Solventum's $4.1B sale of its purification business to Thermo Fisher significantly reduces debt and enhances financial stability, improving long-term prospects. Despite near-term earnings ...